LogicMark, Inc.

LGMK ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-7.5M $-9.0M $-14.6M $-6.9M $-11.7M $-2.9M $-11.8M $-7.1M
Depreciation & Amortization $2.0M $1.6M $944.6K $828.1K $791.0K — — —
Depreciation $87.6K $114.6K $105.7K $26.9K $29.2K $65.8K $74.1K $143.9K
Amortization $761.8K $761.8K $761.8K $776.8K $761.8K $761.8K $761.8K $761.8K
Stock-Based Compensation $1.2M $1.6M $1.6M $1.6M $937.0K $160.0K $607.7K $989.7K
Net Cash from Operating Activities $-5.1M $-4.3M $-4.3M $-3.6M $-5.9M $-313.0K $2.2M $-50.2K
Investing Activities
Capital Expenditures $71.3K $25.6K $53.4K $282.5K — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-7.3M $-1.5M $-1.4M $-1.3M — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $12.1M $3.1M $5.0M $-300.0K $13.6M $3.1M $-2.0M —
Net Change in Cash — — — — — — $122.7K $-4.1M
Free Cash Flow $-5.1M $-4.3M $-4.4M $-3.9M — — — —
← Newer Page 1 of 2 Older →